Indication (pathologie):
Diabetes type
Identifiant SNOMED-CT:
SCTID 405751000
Etudes cliniques
-
Impact of exercise training on body composition, cardio-respiratory function, glycemic control and β cell function/survival according to diabetes etiologyRecrutement: Ouvert
-
Apport de l’échographie et de la cytologie dans le bilan d’un nodule thyroïdien chaudIndication (pathologie):Thyroid noduleIdentifiant SNOMED-CT:SCTID 237495005Recrutement: Ouvert
-
A double-blind, placebo-controlled, randomized trial to determine the safety and efficacy of EMA401 100 mg b.i.d. in reducing 24-hour average pain intensity score in patients with painful diabetic neuropathyIndication (pathologie):Chronic painful diabetic neuropathyIdentifiant SNOMED-CT:SCTID 193184006Phase de l'étude: Phase IIRecrutement: Ouvert
-
COLIBRI STUDY: connecting laboratory information with behaviour for recent infectionIndication (pathologie):Human immunodeficiency virus infectionIdentifiant SNOMED-CT:SCTID 86406008Recrutement: Ouvert
-
Multi-center, randomized non-inferiority trial of early treatment versus expectative management of patent ductus arteriosus in preterm infantsIndication (pathologie):Patent ductus arteriosusIdentifiant SNOMED-CT:SCTID 83330001Phase de l'étude: Phase IVRecrutement: Ouvert
-
L'éducation thérapeutique du patient insuffisant rénal chronique, quels bénéfices?Indication (pathologie):Chronic renal failureIdentifiant SNOMED-CT:SCTID 90688005Recrutement: Ouvert
-
A Phase 3b, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of TRC101 in Delaying Chronic Kidney Disease Progression in Subjects with Metabolic AcidosisIndication (pathologie):Chronic kidney diseaseIdentifiant SNOMED-CT:SCTID 709044004Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A 12 month, partially-blinded, active-controlled, multicenter, randomized study evaluating efficacy, safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) of an anti-CD40 monoclonal antibody, CFZ533, in de novo and maintenance kidney transplant recipientsIndication (pathologie):Transplant of kidneyIdentifiant SNOMED-CT:SCTID 70536003Phase de l'étude: Phase IIRecrutement: Ouvert
-
Prevalence of asymptomatic bacteriuria among kidney transplant recipients: a multicenter, prospective, cross-sectional studyIndication (pathologie):Transplant of kidneyIdentifiant SNOMED-CT:SCTID 70536003Recrutement: Ouvert
-
A randomized, multicenter, double-blind, parallel-group, active-control study of the efficacy and safety of sparsentan for the treatment of immunoglobulin A nephropathyIndication (pathologie):Immunoglobulin A nephropathyIdentifiant SNOMED-CT:SCTID 236407003Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A phase III, randomized, double-blind, active comparator-controlled study to evaluate the efficacy and safety of MK-8228 (Letermovir) versus valganciclovir for the prevention of human cytomegalovirus (CMV) disease in adult kidney transplant recipientsIndication (pathologie):Human cytomegalovirusIdentifiant SNOMED-CT:SCTID 243579005Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A randomized, double-blind, placebo controlled study to evaluate efficacy and safety of Nefecon in patients with primary IGA nephropathy at risk of progressing to send-stage renal diseaseIndication (pathologie):Primary immunoglobulin A nephropathyIdentifiant SNOMED-CT:SCTID 68779003Phase de l'étude: Phase IIIRecrutement: Ouvert
-
A randomized, double-blind, placebo-controlled, phase 2 study to evaluate the safety and efficacy of avacopan (CCX168) in patients with c3 glomerulopathyIndication (pathologie):Glomerular diseaseIdentifiant SNOMED-CT:SCTID 197679002Phase de l'étude: Phase IIRecrutement: Ouvert
-
Essai de phase 3 portant sur le marizomib en association avec une radiochimiothérapie standard à base de témozolomide en monothérapie chez des patients atteints d’un glioblastome nouvellement diagnostiquéIndication (pathologie):Glioblastoma multiformeIdentifiant SNOMED-CT:SCTID 393563007Phase de l'étude: Phase IIIRecrutement: Ouvert
-
Analyse de la balance sagittale cervicale dans le cadre de la mise en place de prothèse discale cervicale avec uncuscectomie et ses répercussions cliniquesIndication (pathologie):CervicobrachialgiaIdentifiant SNOMED-CT:SCTID 76807004Recrutement: Ouvert
-
Use of CADISS Medical Devices to facilitate dissection of epidural fibrosis in patients who undergo revision in spine surgery after at least one yearRecrutement: Ouvert
-
A multicentre, non-interventional study to assess the real-world effectiveness of ocrelizumab in patients with relapsing or primary progressive multiple sclerosis - the musicale studyIndication (pathologie):Primary progressive multiple sclerosisIdentifiant SNOMED-CT:SCTID 428700003Indication (pathologie):Progressive relapsing multiple sclerosisIdentifiant SNOMED-CT:SCTID 724778008Phase de l'étude: Phase IVRecrutement: Ouvert
-
An open-label, multicenter, extention study to evaluate the safety and efficacy of padsevonil as adjunctive treatment of focal-onset seizures in adult subjects with drug-resistant epilepsyIndication (pathologie):EpilepsyIdentifiant SNOMED-CT:SCTID 84757009Phase de l'étude: Phase IIRecrutement: Ouvert
-
Multi-modal and bedside electrophysiological prognostic biomarkers for recovery in ischemic strokeIndication (pathologie):Ischemic strokeIdentifiant SNOMED-CT:SCTID 422504002Recrutement: Ouvert
-
A prospective, open-label, multicenter, single-arm observational registry to describe adherence in relapsing remitting multiple sclerosis patients being prescribed teriflunomide (AUBAGIO®) in Belgium and Luxembourg in routine clinical practiceIndication (pathologie):Multiple sclerosisIdentifiant SNOMED-CT:SCTID 24700007Recrutement: Ouvert